Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Case Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
BeiGene
Northwestern University
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Canadian Cancer Trials Group
City of Hope Medical Center
Eastern Cooperative Oncology Group
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Celgene
National Cancer Institute (NCI)
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Case Comprehensive Cancer Center
Takeda
Barbara Ann Karmanos Cancer Institute
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
University of Washington
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center